NCT03433040View on ClinicalTrials.gov

17OHP-C Dosing Among Obese Pregnant Women

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 23, 2017

Primary Completion Date

June 1, 2021

Study Completion Date

July 14, 2021

Conditions
Premature BirthAbsorption; Chemicals
Interventions
DRUG

17-Hydroxyprogesterone Capronate

17-Hydroxyprogesterone Capronate 250mg versus 500mg

Trial Locations (2)

33606

University of South Florida, Tampa

63110

Washington University in St Louis, St Louis

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

lead

University of South Florida

OTHER

NCT03433040 - 17OHP-C Dosing Among Obese Pregnant Women | Biotech Hunter | Biotech Hunter